CXCR4 antagonist peptide for stem cell mobilisation. Motixafortide is a cyclic peptide that blocks the CXCR4 receptor to mobilise blood stem cells, used with filgrastim before autologous transplantation in multiple myeloma. Available for research, development and custom synthesis projects.